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BJ6RKLUND (1960) described the lysis of HeLa cell cultures by a serum factor,
cytolytic factor, distinct from the four fractions of complement, and proposed
that this agent is released by antigen-antibody reactions to cause cell lysis. Part
of these results was confirmed by Blaney, Rotte and Siler (1964). This study
investigates the preparation of cytolytic factor by column electrophoresis and its
effect on HeLa and leukaemic cells in vitro and on superficial human tumours
in vivo.
Preparation of Cytolytic Factor
In order to provide sufficient material for clinical purposes, cytolytic factor
was isolated from inactivated human serum by column electrophoresis using the
L.K.B. Porath Electrophoresis Column. A volatile ammonium carbonate-
bicarbonate buffer which can be removed from the final product by freeze-drying
was used. Separation was carried out on an ethanolysed cellulose column
(Munktell Cellulose powder, Sweden), under the following conditions: 10' C.,
potential 500-600 volts (0.4 A). Separation was stopped when the albumen
was 3-5 cm. from the anode, usually after about 18 hours. Ten fractions were
obtained, freeze-dried and biological testing carried out on those shown to be
free from the ammonium bicarbonate buffer.
Biological Testing of Fractions
Fractions were prepared for testing in Simm's balanced solution (BSS) at a
concentration of 20 mg./ml. at 0° C. The resistance was adjusted to be identical
with Simms BSS (using a L.K.B. 5300 A Conductolyzer) and the pH was made 7-4.
The solution was filtered through a Hemmings 0.5-1 micron mesh filter and serial
two-fold dilutions prepared in Simms BSS.
Tube culture of HeLa cells (strain S.W.E.) containing 100,000 cells/tube in
0.5 ml. inoculum were used for the test. The growth medium (T.C. 199 with
20% calf serum) was removed and 0.5 ml. of the fractions added using three
tubes per dilution. Control cultures in Simms BSS were set up. The cultures
were examined at 22-24 hours after cell degeneration. The degree of cell
degeneration was scored as follows:
DC ... All cells dead (none attached to tube wall)
(DC) ... Few cells remaining
++ ... Granulation of cytoplasm clearly visible
+ ... Granulation of cytoplasm visible
... Normal cell sheetW. D. MACKAY, J. D. COOMBES AND B. BJORKLUND
The minimum dilution to give a DCreading was taken as a basis for comparison.
A unit of cytolytic activity (HeLa Cell Unit) was defined as the minimum amount
of cytolytic factor in 05 ml. required to produce a DC reading after 24 hours
incubation.
Fig. 1 shows that the fractions containing the greatest activity of cytolytic
factor were those which migrated most rapidly on electrophoresis. Most of the
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FIG. 1.-A typical separation of 150 ml. serum by electrophoresis using a Porath Column.
Indicates the cytolytic factor activity,
- - - represents the recovered weight of the serum fractions.
The approximate composition of the fractions in terms of the major serum protein groups
is indicated.
active fractions contain albumen but immune-electrophoresis shows that pre-
albumen is also present. Fractions of great activity were composed of a low
proportion of albumen to pre-albumen which suggests that a component of pre-
albumen is responsible for the cytolytic activity.
(a) Topical application
Clinical Te8ting
Freeze-dried cytolytic factor was used. Two cases with recurrent skin
nodules from breast cancers andfour cases ofrodent ulcerwere treated. Powdered
cytolytic factor was applied every second or third day for one to three weeks.
EXPLANATION OF PLATE.
FIG. 2.-Case 3. Rodent ulcer after infiltration with cytolytic factor showing
infiltration with chronic inflammatory cells.
FIa. 3.-Case 3. Rodent ulcer. Before infiltration.
FIG. 4.-Case 6. Rodent ulcer. After infiltration with cytolytic factor.
268BIUTISH JuOTRNAVL OF CAN-CER.
2
VO1. XX, NO. 2.
.......
* Sw
*s Irl e
4
Alackay, Coonibes and BiorklundTESTING CYTOLYTIC FACTOR
The tumour was photographed and measured with calipers at intervals. No
change was seen in any of the tumours.
(b) Infiltration of tumours
Sterile cytolytic factor dissolved in saline was used. Six rodent ulcers were
treated with cytolytic factor at a concentration of 5 HeLa Cell Units per ml.,
and three secondary carcinoma deposits were treated with cytolytic factor at a
concentration of 75 HeLa Cell Units per ml. The tissues around the tumour were
infiltrated with 1 / xylocaine with adrenaline and the tumour infiltrated with
as much cytolytic factor as possible. The total dose varied between 1-2 ml.
Two cases altered after treatment. Case No. 3, a rodent ulcer, was infiltrated
with 5 HeLa Cell Units of cytolytic factor and histological examination of the
excised specimen two weeks after infiltration showed a marked inflammatory
cell infiltrate (Fig. 2).
Case No. 6. A rodent ulcer, was infiltrated with 5 HeLa Cell Units ofcytolytic
factor. After two weeks 850%0 of the ulcer had re-epithelialized in two weeks
(Fig. 3 and 4).
A fall in white cell count did not occur in any patient.
Incubation of Cytolytic Factor and Blood In Vitro
0.5 ml. fresh heparinized blood was incubated with an equal volume ofmedium
199. Five specimens of normal blood and two ofleukaemic blood were incubated
with 10 HeLa Cell Units/ml. cytolytic factor. Total white cell counts were
carried out at intervals. At the level of 10 HeLa Cell Units/ml. no change was
found between the cell counts in blood with cytolytic factor and control blood
without cytolytic factor.
The results with 75 HeLa Cell Units/ml. are seen in Table I.
TABLE I. White Cell Counts of Blood Incubated with 75 HeLa Cell Units/mi.
Time
(hours) Leukaemic C.F. Control Normal C.F. Control
0 . 34,000 39,000 12.000 . 13,000
1 . 32,400 . 32,450
2 29,500 29,750 11,200 . 10,650
4 . 27,000 . 27,700 10,560 . 11,250
24 4,000 . 22,450 . 2,500 4,600
Although the figures show a reduction in the white cells in leukaemic blood
this was accompanied by marked lysis ofthe red cells as shown by the appearance
of a chocolate pigment and the demonstration of free haemoglobin and a trace of
methaemoglobin by spectrophotometric examination of the blood.
DISCUSSION
Before it can be accepted that the lytic activity obtained in these experiments
is due to a true component of serum other causes of cell lysis must be considered.
The lysis might be due to contamination with buffer or to changes produced by
the action of cellulose on the serum. If this were the case, it would be expected
that the lytic activity would occur randomly among the serum fractions and
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not be found only in fractions with pre-albumen. It is unlikely that the high
concentration of protein causes the lysis because similar amounts of protein were
present in other fractions without lysis occurring. This evidence suggests that
the lytic agent is a true component of serum, and not an artefact induced by the
experiment.
The active lytic factor occurred in the same factions separated by column
electrophoresis as Bjorklund found when the separation was by curtain electro-
phoresis. Heating to 560 does not destroy the activity. It would appear,
therefore, that this lytic agent is identical to the cytolytic factor described by
Bjorklund.
The clinical trial was carried out using topical application and local infiltration
because cytolytic factor is quickly inactivated by serum which makes possible
intravenous or intra-arterial administration difficult. By using the topical and
infiltration methods ofadministration it was hoped to bring the active preparation
into close proximity to the cancer cells.
Changes were produced in only two cases. This may have been due to several
factors. The dosage of cytolytic factor may have been too low, the powdered
preparation may not have been absorbed, and serum may inhibit the preparation
too quickly.
The results obtained with in vitro incubation show that, at high cencentrations,
cytolytic factor will destroy red cells and white cells and that this represents a
non-specific lytic activity rather than any specific activity against leukaemic cells.
Although cytolytic factor will cause lysis of tumour cells in vitro, attempts
to use it in vivo on 15 superficial human tumours have only produced small
changes in two cases. Thus in these preliminary experiments no changes
considered to represent an anti-tumour effect were observed.
SUMMARY
A method ofpreparing a cytolytic factor from serum by column electrophoresis
is described. This factor has a marked lytic effect on HeLa cells in tissue culture,
but preliminary investigations of its effect on human cancer in vivo have not
produced any significant anti-tumour effect.
Part of this work was carried out by one author (W. D. M.) during the tenure
of a grant from the British Empire Cancer Campaign for Research. We are
grateful to Mr. P. Ramsbottom who performed the biological testing in this work,
and to the Physicians at King's College Hospital for permission to study their
patients.
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